Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab



Status:Archived
Conditions:Renal Impairment / Chronic Kidney Disease
Therapuetic Areas:Nephrology / Urology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:September 2009
End Date:September 2010

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The goal of the study is to find out the effects of two different drugs used at the
beginning of organ transplantation on different populations of immune cells in the body of
patients.



We found this trial at
1
site
Brigham & Women's Hospital Women's Health Center
850 Boylston Street
Chestnut Hill, Massachusetts 02467
1-800-BWH-9999
Brigham & Women's Hospital Women's Health Center At Brigham and Women
?
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials